Patient
ALX-S002
screened Phase IA Phase 1 Study to Evaluate Intratumoral Doxorubicin Exposure Following Administration of Aldoxorubicin or Doxorubicin · The University of Texas MD Anderson Cancer Center (Houston, TX) (Dr. Reyes)
Adverse events
0
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 0
No adverse events recorded
Events reported by the site or through Luna appear here.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.